BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

3:55 PM
 | 
Sep 07, 2018
 |  BC Extra  |  Company News

Amid launch troubles, Portola commercial chief Fu resigns

With its stock price near its 52-week low amid a disappointing launch of anticoagulant Bevyxxa betrixaban, Portola Pharmaceuticals Inc. (NASDAQ:PTLA) said EVP and Chief Commercial and Business Officer Tao Fu is resigning to pursue other opportunities, effective Sept. 21. The change occurs while Portola continues to search for a successor to CEO Bill Lis, who retired Aug. 1 as planned.

Portola said it is working with an executive search firm to find Fu's successor in parallel with Lis'. Interim Co-President and CFO Mardi Dier is leading Portola's commercial operations, while...

Read the full 429 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >